Therefore, through separate and complementary mechanisms, the inclusion of insulin into ARG treatment regimens has genuine potential to increase the efficacy of arginine depletion in vivo and warrants further investigation to determine whether combination with ARG affects the ability of ARG to induce cancer cell death. The gene discussed is INS; the disease is cancer.